NNOX logo

Nano-X Imaging Ltd. Stock Price

NasdaqGM:NNOX Community·US$132.9m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 82 Fair Values set on narratives written by author

NNOX Share Price Performance

US$1.84
-3.29 (-64.13%)
US$6.65
Fair Value
US$1.84
-3.29 (-64.13%)
72.3% undervalued intrinsic discount
US$6.65
Fair Value
Price US$1.84
AnalystConsensusTarget US$6.65
AnalystLowTarget US$5.00
AnalystHighTarget US$10.00

NNOX Community Narratives

·
Fair Value US$6.65 72.3% undervalued intrinsic discount

Digital Diagnostics And AI Will Open Global Markets

1users have liked this narrative
0users have commented on this narrative
56users have followed this narrative
·
Fair Value US$5 63.2% undervalued intrinsic discount

Rising Regulatory Hurdles Will Test Digital Imaging But Allow Revival

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
·
Fair Value US$10 81.6% undervalued intrinsic discount

Global Aging And Digitalization Will Accelerate Imaging Adoption

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
US$6.65
72.3% undervalued intrinsic discount
Profit Margin
5.12%
Future PE
128.12x
Price in 2029
US$8.46
US$5
63.2% undervalued intrinsic discount
Profit Margin
5.12%
Future PE
73.14x
Price in 2029
US$6.35

Trending Discussion

Updated Narratives

NNOX logo

NNOX: Reset Expectations And New Distribution Deals Could Support Upside

Fair Value: US$6.65 72.3% undervalued intrinsic discount
56 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
NNOX logo

NNOX: New Distribution Agreements Will Support Future Imaging Deployment Upside

Fair Value: US$5 63.2% undervalued intrinsic discount
5 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
NNOX logo

Global Aging And Digitalization Will Accelerate Imaging Adoption

Fair Value: US$10 81.6% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Excellent balance sheet with limited growth.

1 Risk
1 Reward

Nano-X Imaging Ltd. Key Details

US$13.0m

Revenue

US$25.8m

Cost of Revenue

-US$12.8m

Gross Profit

US$62.2m

Other Expenses

-US$75.0m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-1.08
-98.21%
-576.13%
2.2%
View Full Analysis

About NNOX

Founded
2011
Employees
197
CEO
Erez Meltzer
WebsiteView website
www.nanox.vision

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company’s solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data of existing computed tomography scans; and Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. In addition, the company provides Real+ Osteoporosis Care Management Platform, a osteoporosis care management software platform; AI-Based Aortic Valve Calcification Measurement, an artificial intelligence–based solution; AI-Based Body Composition Measurement, an artificial intelligence–based body composition analysis capability; and Nanox Health IT, a healthcare information technology services provider that serves hospitals and other healthcare organizations. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Petah Tikva, Israel.

Recent NNOX News & Updates

Seeking Alpha May 12

Nano-X Imaging: Too Cheap To Ignore, Too Early To Buy

Summary Nano-X Imaging (NNOX) offers an integrated, FDA-cleared imaging platform targeting underserved clinics with affordable hardware, AI diagnostics, and teleradiology services. NNOX faces critical execution risk, with only 36 systems deployed and a $35M 2026 revenue target hinging on a significant ramp in the next two quarters. The company holds $60M in cash, burning $40M annually, and may require additional financing if revenue growth lags, posing dilution risk. I recommend holders wait for Q1 2026 results on May 20; potential buyers should remain on the sidelines until execution is demonstrated. Read the full article on Seeking Alpha

Recent updates

No updates